Anna Gambaro
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- COVID-19 and healthcare impacts
- Cancer-related Molecular Pathways
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 9
- COVID-19 and healthcare impacts 6
- Cancer Immunotherapy and Biomarkers 3
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Raffaella Palumbo (6 shared papers)Federico Sottotetti (6 shared papers)Antônio Bernardo (7 shared papers)Barbara Tagliaferri (8 shared papers)Cristina Teragni (6 shared papers)Davide Dalu (15 shared papers)Eliana Rulli (8 shared papers)Marina Elena Cazzaniga (4 shared papers)
- Journals
- Annals of Oncology (4 papers)International Journal of Molecular Sciences (2 papers)Breast Cancer Research and Treatment (2 papers)Therapeutic Advances in Medical Oncology (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Anna Gambaro
26 papers receiving 193 citations
Peers
Comparison fields: 5 of 50
- Oncology 144
- Cancer Research 63
- Pulmonary and Respiratory Medicine 75
- Genetics 14
- Infectious Diseases 16
Countries citing papers authored by Anna Gambaro
This map shows the geographic impact of Anna Gambaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gambaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gambaro more than expected).
Fields of papers citing papers by Anna Gambaro
This network shows the impact of papers produced by Anna Gambaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gambaro. The network helps show where Anna Gambaro may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Gambaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 43 | |
| 2 | 2015 | 34 | |
| 3 | 2021 | 17 | |
| 4 | 2017 | 12 | |
| 5 | 2019 | 12 | |
| 6 | 2019 | 11 | |
| 7 | 2020 | 7 | |
| 8 | 2021 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2017 | 6 | |
| 11 | 2015 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2009 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 1997 | 2 |
About Anna Gambaro
Anna Gambaro is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, Cancer Research and Pathology and Forensic Medicine, having authored 30 papers that have together received 199 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (9 papers), Advanced Breast Cancer Therapies (7 papers), COVID-19 and healthcare impacts (6 papers), Breast Cancer Treatment Studies (4 papers), COVID-19 Clinical Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Oncology (144 citations), Cancer Research (63 citations), Pulmonary and Respiratory Medicine (75 citations), Genetics (14 citations) and Infectious Diseases (16 citations). Anna Gambaro has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Raffaella Palumbo, Federico Sottotetti, Antônio Bernardo, Barbara Tagliaferri, Cristina Teragni, Davide Dalu, Eliana Rulli, Marina Elena Cazzaniga, Nicla La Verde and Mariangela Ciccarese. Their work appears in journals such as Annals of Oncology, International Journal of Molecular Sciences, Breast Cancer Research and Treatment, Therapeutic Advances in Medical Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.